These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7310012)

  • 1. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm.
    Ungerer RG; Tashkin DP; Siegel SC; Deutsch RI
    J Allergy Clin Immunol; 1981 Dec; 68(6):471-8. PubMed ID: 7310012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
    Watt GD; Bui TC; Bewtra AK; Townley RG
    J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
    Mann JS; Clement P; Sheridan AQ; Soryal I; Fairfax AJ; Holgate ST
    J Allergy Clin Immunol; 1985 Jul; 76(1):83-90. PubMed ID: 4008815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of antigen-induced bronchoconstriction by lodoxamide ethyl, a new orally active antiallergic drug.
    Katcher ML; Reed CE
    J Allergy Clin Immunol; 1980 Sep; 66(3):223-6. PubMed ID: 7410746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lodoxamide tromethamine on the immediate asthmatic response to allergen provocation.
    Ollier S; Graham VA; Bentley S; Davies RJ
    Clin Allergy; 1982 Nov; 12(6):587-94. PubMed ID: 7151268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.
    Parrish RW; Davies BH
    Thorax; 1983 Jun; 38(6):458-62. PubMed ID: 6136101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of lodoxamide on antigen-induced bronchospasm. An orally active antiallergic drug.
    Case RL; Rogers PB; VanArsdel PP; Altman LC
    JAMA; 1982 Feb; 247(5):661-4. PubMed ID: 7033581
    [No Abstract]   [Full Text] [Related]  

  • 8. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
    Johnson HG; Sheridan AQ
    Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lodoxamide tromethamine on paraplegia that occurs after infrarenal aortic occlusion in the rabbit.
    Ball TD; Lundy EF; Zelenock GB; D'Alecy LG
    J Vasc Surg; 1987 Dec; 6(6):572-7. PubMed ID: 3694755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of ischemia-reperfusion injury by the allergy drug lodoxamide tromethamine.
    Parenteau GL; Clark RE
    Ann Thorac Surg; 1991 Oct; 52(4):832-8. PubMed ID: 1929638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S; Schiavone M; Bonini S; Magrini L; Lischetti P; Lambiase A; Bucci MG
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lodoxamide tromethamine prevents neutrophil accumulation in reexpansion pulmonary edema.
    Veal CF; Jackson RM; Brannen AL; Fulmer JD
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):227-32. PubMed ID: 2476595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of iodoxamide ethyl on allergy skin tests.
    Frigas E; Reed CE
    J Allergy Clin Immunol; 1980 Apr; 65(4):257-62. PubMed ID: 7358942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lodoxamide on the secretory response induced by Escherichia coli and Vibrio cholerae enterotoxins in infant mice.
    Knoop FC; Thomas DD
    Infect Immun; 1984 May; 44(2):406-8. PubMed ID: 6143729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the variance components in a pharmaceutical aerosol product: lodoxamide tromethamine.
    Havel HA; Beaubien LJ; Haaland PD
    J Pharm Sci; 1985 Sep; 74(9):978-82. PubMed ID: 4067853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.
    Caldwell DR; Verin P; Hartwich-Young R; Meyer SM; Drake MM
    Am J Ophthalmol; 1992 Jun; 113(6):632-7. PubMed ID: 1598953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol and lodoxamide in complement-induced hepatic ischemia.
    Schirmer WJ; Schirmer JM; Naff GB; Fry DE
    J Surg Res; 1988 Jul; 45(1):28-36. PubMed ID: 3260642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lodoxamide treatment of allergic conjunctivitis.
    Cerqueti PM; Ricca V; Tosca MA; Buscaglia S; Ciprandi G
    Int Arch Allergy Immunol; 1994 Oct; 105(2):185-9. PubMed ID: 7920019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lodoxamide on ischemic reperfused myocardium.
    Jolly SR; Abrams GD; Romson JL; Bailie MB; Lucchesi BR
    J Cardiovasc Pharmacol; 1982; 4(3):441-8. PubMed ID: 6177941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.